How do I buy Travere Therapeutics (TVTX) stock?

You can purchase shares of Travere Therapeutics (NASDAQ:TVTX) through any online brokerage.View our list of the best stock brokerages

Who are Travere Therapeutics (TVTX) competitors?

Other companies in Travere Therapeutics’s space includes: IDEAYA Biosciences Inc (NASDAQ:IDYA), Sarepta Therapeutics Inc (NASDAQ:SRPT), Centessa Pharmaceuticals PLC (NASDAQ:CNTA), Ascentage Pharma Group International (NASDAQ:AAPG) and Arcutis Biotherapeutics Inc (NASDAQ:ARQT).

What is the forecast, or price target, for Travere Therapeutics (TVTX) stock?

Travere Therapeutics has a consensus price target of $35.00.

What is the current price for Travere Therapeutics (TVTX)?

The stock price for Travere Therapeutics (NASDAQ: TVTX) is $22.12 last updated January 12, 2026 at 7:59 PM EST.

Does Travere Therapeutics (TVTX) pay a dividend?

There are no upcoming dividends for Travere Therapeutics.

When is Travere Therapeutics (NASDAQ:TVTX) reporting earnings?

Travere Therapeutics does not have any upcoming earnings scheduled.

Is Travere Therapeutics (TVTX) going to split?

There is no upcoming split for Travere Therapeutics.

What sector and industry does Travere Therapeutics (TVTX) operate in?

Travere Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Travere Therapeutics (TVTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is...

Comments